“The attack on stem cell research has driven at least one regenerative medicine company to seek friendlier climes south of the border. Six months after the federal government forced it to stop its treatments, the Houston-based Celltex Therapeutics moved its operations to Mexico to avoid the long arm of the law. In moving to Mexico, Celltex enters a country where stem cell research is not as heavily regulated as in the U.S, though a facility is required to have an International Health Department Permit (COFEPRIS). The permit allocates the use of stem-cell types beyond those in the U.S.”
Related posts:
Fund manager Ned Goodman ditches bank stocks for gold
BMW takes ‘great leap forward’ into electric car market
Famed Trader Joe Lewis Backs Bitcoin With Swiss Fund
South Korean troops kill man trying to swim North
Help Thy Neighbor and Go Straight to Prison
TSA's VIPR could be screening you without you knowing it
Sky News cameraman Mick Deane killed in Cairo violence
Gold at a huge premium as Indian imports dry up; survival of small jewellers at stake
Bureaucrats Paid $250,000 Feed Outcry Over College Costs
Canines’ Cancer-Sniffing Snouts Showing 90%-Plus Accuracy
Wal-Mart sues Visa for $5 billion over card swipe fees
Indian starving children’s fund used to fix buses
Collection of phone records stirs debate: Valuable tool or 'beyond Orwellian'?
FDA rewrites opioid narcotic labels to limit use for pain
High school students suspended for possession of energy mints